Lyra Therapeutics, Inc.

LYRA

—

Advanced chart & tools →

Lyra Therapeutics, Inc.LYRA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-18.62

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$398,000

Net income

$-28.92M

Net margin

-7266.1%

Gross margin

—

Dividends & financials

Lyra Therapeutics, Inc. (LYRA) reported revenue of $398,000 and net income of $-28.92M, or $-18.62 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.